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 Abstract 
The multidisciplinary team (MDT) approach illustrates how motor classification systems, 
assessments and outcome measures currently available have been applied to a national cohort 
of children and young people with dystonia and other hyperkinetic movement disorders 
(HMD) particularly with a focus on dyskinetic cerebral palsy (CP). The paper is divided in 3 
sections.  Firstly, we describe the service model adopted by the Complex Motor Disorders 
Service (CMDS) at Evelina London Children’s Hospital and King’s College Hospital (ELCH-
KCH) for deep brain stimulation. We describe lessons learned from available dystonia studies 
and discuss/propose ways to measure DBS and other dystonia-related intervention outcomes. 
We aim to report on current available functional outcome measures as well as some 
impairment-based assessments that can encourage and generate discussion among movement 
disorders specialists of different backgrounds regarding choice of the most important areas to 
be measured after DBS and other interventions for dystonia management. Finally, some 
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recommendations for multi-centre collaboration in regards to functional clinical outcomes and 
research methodologies for dystonia-related interventions are proposed.  
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Childhood dystonia 
Hyperkinetic movement disorders (HMD) 
Deep Brain Stimulation (DBS) 
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Background 
Objective measurement across all domains of the International Classification of Functioning 
(ICF), Disability and Health (1) has been recommended as an essential element in 
rehabilitation (2-4). These include i) body function and structures, ii) activity and iii) 
participation. Whilst body function and structures focuses on impairments, activity and 
participation domains include concepts such as capacity and limitations and restrictions. This 
framework has been widely adopted to define and measure health and disability. It provides 
common terminology for professionals internationally and from different backgrounds. The 
focus is on the child and the interaction with two other key domains of the ICF, i) the 
environment taking into account impairments but also ii) contextual factors such as personal 
ones. The evaluation of the different dimensions across the ICF allows better representation 
of the child’s needs, strengths and living experience with dystonia with emphasis on family-
centred care, the use of functional outcome measures, and measuring how children and young 
people with disabilities can live meaningful lives.   
Despite 15 years since the ICF framework was published, much of the current research in 
childhood dystonia and other hyperkinetic movement disorders (HMD) has concentrated on 
genetic diagnoses and other aetiologies. The interventional studies available in childhood 
dystonia and other HMD focus in the majority on outcomes within the impairment level 
without attempting to elaborate on what this might mean at the levels of activity and 
participation (5).  A recent Lancet review by Koy et al. (2016) (6) on the management of 
movement disorders in children outlines a number of recommendations including better trials 
of interventions, preferably disease-modifying, optimized for different age groups of children 
and using appropriate assessment scales that can be universally employed across all childhood 
dystonias from isolated monogenetic, acquired brain injury to heredodegenerative and 
neurometabolic causes of childhood dystonia. 
Childhood dystonia and other hyperkinetic movement disorders (HMD) are a heterogeneous 
group in terms of aetiology, motor severity, functional abilities, motor and non-motor co-
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morbidities.  Dystonia is a neurological syndrome characterised by involuntary, patterned, 
sustained, or repetitive muscle contractions of opposing muscles, resulting in abnormal 
twisting body movements and abnormal postures (7, 8) which can also be tremulous. 
Dystonia affects adults and children and is one of the most disabling movement disorders, 
both for the individual and their families. The causes and clinical presentations of dystonia are 
heterogeneous, and dystonia has mostly been classified by aetiology within two broad 
categories:  
i. Primary dystonias have no structural brain abnormality and often no known underlying 
cause, although genetic mutations are being increasingly identified e.g. DYT1; DYT6; 
DYT11 and many others though genetic heterogeneity and phenotypic pleiotropy is also 
increasingly recognised (9).  
ii. Secondary dystonias, including Cerebral Palsy (10) in which structural abnormalities of 
the brain are usually visible arising from perinatal injuries such as periventricular 
leukomalacia (PVL), hypoxic-ischaemic encephalopathy (HIE), kernicterus, localised 
strokes of the basal ganglia, cortical and subcortical malformations including hypo- and 
dys-myelinating disorders and an extremely wide range of individually rare but 
collectively important neurometabolic disorders as well as neurodegenerative disorders 
such as Neurodegeneration with Brain Iron Accumulation (NBIA) (6, 7, 11, 12).  
More recently, Albanese and colleagues (8) have proposed a new classification based on two 
axes:  
Axis 1: Age at onset, body distribution, temporal pattern and associated features (additional 
movement disorders or neurological features). 
Axis 2: Aetiology, which includes nervous system pathology and inheritance, to “provide 
meaningful information on any dystonia patient and serve as a basis for the development of 
research and treatment strategies”.   
This classification could be useful in very large cohorts of patients such as an international 
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database for example as launched by Marks and colleagues (2016) (13). The grouping of all 
variables into pragmatic, yet clinically appropriate, subgroups might be needed in order to 
make clinical sense of results across different groups of patients. We have briefly reported 
(14) the newly proposed classification system to a sample of 145 children and young people 
presenting with dystonia to a tertiary centre however the application of the classification 
system resulted in 4 major sub-groups: 1) primary dystonia, ii) primary plus dystonia, iii) 
secondary static dystonia and iv) heredodegenerative conditions.  
Deep Brain Stimulation (DBS) of the Globus Pallidus has now been established as an 
effective intervention for primary dystonia, in both controlled (15) and open label studies (16) 
as well as long term studies (17) and for a general review of DBS in children see Lin 2016 
(18-20). In addition, the UK’s National Institute for Health and Clinical Excellence (NICE) 
have approved DBS for parkinsonism (although Parkinsonism is rare in children), dystonia 
and tremor movement disorders in adults and children and have also provided guidelines 
supporting the use of DBS as a safe and efficacious procedure for dystonia and tremor (21). 
Despite these well conceived and described studies, the functional status and recovery of even 
primary dystonias following DBS has not yet been well-described and young people continue 
to face significant functional difficulties despite an impressive motor recovery from dystonia 
impairment, indicating that primary dystonia is a disorder affecting motor function beyond 
motor skills alone (22). Non-motor symptoms have been described in primary dystonia in the 
adult population (23-26) but reports in paediatrics are lacking and more research in this area is 
needed.  
 
There are known to be around 70,000 sufferers of dystonia in the UK alone (27). Although 
there is evidence of a falling prevalence of CP arising from moderately low birth-weight 
(MLBW) and very low birth-weight (VLBW) in Europe for the period 1980-2003 with an 
overall fall in prevalence from 1.9 to 1.77/1000 live births. The prevalence of CP in normal 
birth-weight (NBW) babies (i.e. the majority of cases) and extremely low birth-weight infants 
remain unchanged. Also, the prevalence of dyskinetic (dystonic-choreoathetosis) CP has 
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remained unchanged at 3.5, 4.3 and 4-8% for ELBW, VLBW and MLBW babies respectively 
and 10.8% for NBW babies (28). 
 There is also an increasing acceptance that dyskinetic CP is under-recognised in the CP 
population in general due to lack of appropriate operational definitions of clinical 
phenomenology with evident consequences for appropriate management (10, 29, 30). The use 
of the hypertonus assessment tool (HAT) may also help distinguish dystonia from spasticity 
(31).  
 
Limitations of the standard pharmacological and therapeutic interventions for the 
management of both primary and secondary childhood dystonias (6, 32) and inexorable 
progression to functional musculoskeletal deformity within the first 5-10 years of life (33) 
have therefore resulted in an increasing demand for alternative neuromodulation techniques, 
such as DBS (6). 
Specific studies solely related to the evaluation of outcomes following DBS in childhood 
dystonia are still limited, particularly as only outcomes on reduction of dystonia are often 
shared (5) and functional recovery is not well described in the literature (34).  
 
The heterogeneity of this group of conditions makes it difficult to systematically approach 
measurement across the domains of the ICF, particularly at the level of activity and 
participation and it requires a multidisciplinary approach including AHPs as part of the core 
team managing children and young people with dystonia and other HMD. Perhaps this is one 
of the reasons why research reports regarding functional difficulties and outcomes following 
interventions are lacking. Even when clinical and objective measures are advocated, scales of 
dystonia severity alone persist as the sole outcome measure (35) while emphasising that the 
main goal of rehabilitation is to improve function and reduction of dystonia severity alone 
may not necessarily result in a change in function. It is therefore critical to review available 
and valid functional outcome measures on dystonia. The use of outcome measures in 
childhood dystonia will be addressed later.  
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The multidisciplinary team (MDT) approach illustrates how motor classification systems, 
assessments and outcome measures currently available have been applied to a cohort of 
children and young people with dystonia and other HMD particularly with a focus on cerebral 
palsy (CP). We aim to report on current available functional outcome measures as well as 
some impairment-based assessments that can encourage and generate discussion among 
movement disorders specialists of different backgrounds regarding choosing the most 
important areas to be measured after DBS and other interventions for dystonia management.  
Specific aims of this paper are:  
(1) To describe the Evelina London Children’s Hospital & King’s College Hospital  
(ELCH-KCH) DBS service model and explain the process of creating a ‘Minimal-
acceptable-best practice’ model  
(2) To describe what we have learned from dystonia studies and discuss ways to measure 
DBS outcomes and effects of other interventions for dystonia including the 
challenges faced in measuring outcomes;  
(3) To suggest recommendations for multi-centre collaboration regarding functional 
clinical outcomes and research methodologies for interventions with dystonia 
 
(1) The Complex Motor Disorders Service (CMDS) service model  
The ELCH-KCH DBS service is client-focused and benchmarked to ‘best practice’ criteria as 
proposed by the World Health Organisation’s International Classification of Function (ICF) 
(1). Moving away from impairment-based models of practice, the ICF focuses on activity and 
participation. This philosophy forms the basis of our multidisciplinary client-centred service 
model. Figure 1 shows areas of assessment and intervention in our service model.  
Insert figure 1 here 
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Figure 1: ICF Areas addressed by the MDT in CMDS. This figure illustrates the multi-dimensional 
approach to assessment with examples of some of what outcome measures could be utilised. Not all 
assessments are completed with all children, as this would depend on their level of motor severity and 
manual function ability as well as cognitive ability. 
ABBREVIATIONS: MRI: Magnetic Resonance Imaging; PET: Positron Emission Tomography; 
CMCT: Central Motor Conduction Time; SSEP: Somato-Sensory Evoked Potentials; BFMDRS: Burke-
Fahn-Marsden Dystonia Rating Scale (36); GMFM: Gross Motor Function Measure(37); MA-2: 
Melbourne Assessment – 2(38); BOT-2: Bruininks-Oseretsky Test Of Motor Proficiency (REF); BADS-
C: Behavioral assessment of dysexecutive syndrome (39); NEPSY:Developmental NEuroPSYchological 
Assessment (40); D-KEFS: Delis-Kaplan Executive Function Syndrome(41); WISC: Wecshler 
Intelligence Scale for Children(42); CMS: Children’s Memory Scale(43); PPI: Pediatric Pain 
Profile(44); AMPS: Assessment of Motor and Process Skills(45); PQRS: Performance Quality Rating 
Scale(46); TUG: Time-up and go(47); DASH: Detailed Assessment of Speed Handwriting (48) PEDI-
CAT: Pediatric Evaluation Disability Inventory – Computer Adaptive Test(49); CPCHILD: Caregiver 
Priorities and Child Health Index of Live with Disabilities (50); COPM: Canadian Occupational 
Performance Measure(51); GAS: Goal Attainment Scale(52); ICF: International Classification of 
Functioning(1); MDT: Multidisciplinary Team; CMDS: Complex Motor Disorders Service 
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How the Evelina London Children’s Hospital-King’s College Hospital DBS service began. 
The Evelina DBS service was originally created in 2005 after some inspirational work with 
the Montpellier DBS group.  In 2003 and 2004, two children with extremely severe primary 
idiopathic torsion dystonia (DYT1-positive) were sent from London to Professor Philippe 
Coubes, neurosurgeon in Montpellier, France.  These children were both implanted with 
bilateral Globus Pallidus Internus (GPi) deep brain stimulators, which resulted in a marked 
reduction in their dystonia. 
 
The paediatric Complex Motor Disorders Service (CMDS) began in May 2005 with the first 
bilateral Globus Pallidus Internus (GPi) Deep Brain Stimulation (DBS) implant in a four year-
old boy with dystonia secondary to a rapidly progressive neurodegenerative disorder. The 
functional neurosurgery was performed at King’s College Hospital by Mr. Richard Selway, 
Consultant Functional Neurosurgeon as a joint Guy’s & St Thomas’ & King’s College 
Hospital collaboration. The appropriateness of DBS in 5 clinically selected children with 
severe dystonia was discussed with Professor Phillipe Coubes and Dr Laura Cif who visited 
our unit and advised on clinical issues.  These children then became the service’s first DBS 
cases and lead to the successful funding application for a dedicated multidisciplinary 
Complex Motor Disorders Service (CMDS) by the Guy’s and St Thomas’ Charity which 
began recruiting team members of the CMDS at Evelina London Children’s Hospital (ELCH) 
in April 2007. As with all new services, we have received referrals for young people with 
extreme dystonia at the young adult age-range reflecting the spectrum of unmet need in this 
field of neurology.  
 
The first stage involved defining a multidisciplinary client-focused CMDS for assessment and 
management of children and young people undergoing DBS. At this stage, various factors 
were considered, including listening to the views of children and families being treated, as 
well as careful consideration of governmental and societal guidelines and recommendations, 
all of which highlight the need for multidisciplinary team input. These included: 
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- The National Service Framework (NSF) for Children and Young People (53), whose 
recommendations include (i) listening to families’ feedback in development of services; 
(ii) promoting social inclusion of children with disabilities and facilitation of improved 
function and participation in daily life; and (iii) supporting an MDT approach so that 
services can effectively co-ordinate around the needs of the child and family 
- NICE guidelines for ‘DBS for tremor and dystonia (excluding Parkinson’s disease)’(21), 
which recommend that DBS intervention and care “…should be carried out in the context 
of a multidisciplinary team…” 
- The Dystonia Society UK, which advocates a full MDT assessment process for DBS and 
regular follow-ups to ensure maximum clinical efficiency (27). 
The subsequent NHS approval of DBS for movement disorders (April 2013) with guidance 
notes was not then available (54). 
 
Essential components to our assessment and management service model 
The CMDS team at ELCH-KCH consists of a bespoke multidisciplinary team including 
neurologists, neurosurgeons, a specialist nurse, psychologist, physiotherapist, occupational 
therapist, speech and language therapist and a therapy assistant crucial to the delivery of a 
large ‘battery’ of tests and assessments, video archiving, and consents for assessments 
working in a trans-disciplinary model of practice to meet the needs of the child (55). One of 
our main aims has been to move away from a pure medical-surgical model but rather to adopt 
a family-centred approach reflecting the importance of collaborative partnerships with 
families, clients and others working with the child.  
 
Recently, there has been a shift away from approaches aimed at “fixing” the child/young 
person, instead, the focus is on activity and participation underpinned by the International 
Classification of Functioning (ICF). This shift has been driven by factors such as our 
changing understanding of child development, emphasis on family-centred care, use of 
functional outcome measures and determining what is important for young people with 
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disabilities to live meaningful lives.  This fosters the children’s sense of own competency and 
enables the young person and their family to address factors that also impact on the child’s 
ability “to do”. In short, supporting young people and their families in becoming experts on 
managing their own condition. 
 
Our assessment process includes a repertoire of imaging and medical testing but goes beyond 
the impairment level (as outlined in the WHO ICF framework) and also assesses other areas 
that would affect the child/young person’s ability to participate fully in all activities of daily 
living in the community, albeit within a hospital context.  
 
This multi-disciplinary service has been established to assess the suitability of children with 
complex motor disorders for specialised neurosurgical interventions such as intrathecal 
baclofen (ITB) pump implantation for mixed spasticity and dystonia or deep brain stimulation 
(DBS) for dystonia alone. A number of patients are additionally referred for diagnostic and 
management support.  Patients are referred from all over the United Kingdom and Ireland for 
DBS and more regionally for ITB. A number of international referrals are received, 
predominantly for DBS. Figure 2 represents an outline of the assessment process.  
Insert figure 2 here 
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Figure 2: Assessment Process Outline. This figure represents the multi-dimensional approach to 
assessment before a neurosurgical intervention such as deep brain stimulation (DBS) or intrathecal 
baclofen pump (ITB). The complexity of this model requires the integration and collaboration of a 
multidisciplinary team. 
 
ABBREVIATIONS: MRI: Magnetic Resonance Imaging, PET: Positron Emission Tomography, 
CMCT: Central Motor Conduction Time, SSEP: Somato-Sensory Evoked Potentials, AMPS: 
Assessment of Motor and Process Skills, PQRS: Performance Quality Rating Scale, MA-2: Melbourne 
Assessment – 2, GMFM: Gross Motor Function Measure, TUG: Time-up and go, QoL: Quality of Life, 
BFMDRS: Burke-Fahn-Marsden Dystonia Rating Scale, COPM: Canadian Occupational Performance 
Measure, GAS: Goal Attainment Scale.  
 
The patient journey 
The bespoke multidisciplinary nature of the CMDS is reflected in the patient’s journey; from 
the initial stages of data gathering prior to meeting the child and family, to the final 
discussions, goal-setting and decision-making for DBS or further management options. The 
patient journey involves three phases, which are represented in figures 3a and 3b.   
Insert figures 3a & 3b here 
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Figure 3a: Patient Journey over 1 week admission for assessment and decision tree and follow up 
process. This figure represents the multi-dimensional approach to assessment before a neurosurgical 
intervention such as deep brain stimulation (DBS) or intrathecal baclofen pump (ITB) and the decision 
tree with different phases of assessment, implementation and review.  
ABBREVIATIONS: GA MRI: General Anesthesia Magnetic Resonance Imaging, GA FDG-PET-CT: 
General anesthesia F-Fluorodeoxyglucose Positron Emission Tomography-computed tomographic, 
CMCT: Central Motor Conduction Time, SSEP: Somato-Sensory Evoked Potentials, KCH: King’s 
College Hospital, DBS: Deep Brain Stimulation, ITB: Intrathecal Baclofen, MDT: multidisciplinary 
team 
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Figure 3b. CMDS process over separate hospital visits for assessment and decision tree  
ABBREVIATIONS: GA MRI: General Anesthesia Magnetic Resonance Imaging, GA FDG-PET-CT: 
General anesthesia F-Fluorodeoxyglucose Positron Emission Tomography-computed tomographic, 
CMCT: Central Motor Conduction Time, SSEP: Somato-Sensory Evoked Potentials, KCH: King’s 
College Hospital, DBS: Deep Brain Stimulation, ITB: Intrathecal Baclofen, MDT: multidisciplinary 
team. 
 
Phase 1: Comprises a full MDT assessment including neuro-radiological and neuro-
physiology testing, functional assessments led by allied health professionals (AHP) and a 
range of impairment-based assessments, quality of life and goal setting.   
Phase I can commence (most likely) with a screening clinic run by a consultant neurologist 
from CMDS and a senior AHP (either physiotherapist or occupational therapist). A whole 
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week assessment might be preferable for those cases who are rapidly deteriorating or living 
geographically far from the South East of England. Bearing in mind the capacity of the child 
and families to endure a whole week of assessments including neuroimaging, 
neurophysiology and AHP assessments detailed below. This might be further compounded by 
environmental factors such as bed availability. Before children and families attend their initial 
appointment a questionnaire is sent which allows gathering of preliminary information about 
functional concerns and opening a dialogue with family and child/young person. The 
questionnaires (devised by HG with contributions from other team members) consist of two 
versions based on the GFMCS severity levels (one questionnaire for GFMCS levels I-III and 
the other questionnaire for GFMCS levels IV and V). (These are included here as 
supplementary information – supplementary files 1 and 2). The questionnaires guide 
clinicians at initial screening regarding appropriate assessments. The family concerns are 
paramount and are the focus of much of this initial discussion.  
The detailed standardised assessments will depend on the functional ability of the young 
person but as a rule of thumb, the greater the functional ability, the more assessments it will 
be theoretically possible to complete: the main purpose is to obtain reliable and generalizable 
measures of function and not be pegged by test-limited ceiling effects. The assessments 
illustrated in figure 1 encompass assessments for all GMFCS levels but not all will be 
performed with all the children and young people. On supplementary information (appendices 
3 and 4) we have outlined the assessments that are routinely completed by the MDT in all 
phases of the patient’s journey.  
The steps in phase one are aimed narrowly at confirming suitability for neuromodulation and 
more broadly at mapping the underlying functional residual capacity of the child. This is set 
against what we know about the natural history of dystonia in childhood in all the known 
aetiological categories: i.e. dystonia tends to worsen in 2/3 of cases or stay as bad in a further 
1/3 of cases (11); functional deformities become apparent in secondary dystonias around the 
age of 5 years and then affect 80% of children by age 15 years (33); adverse drug reactions to 
commonly used antidystonic medication are common (32). This background information 
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helps families contextualise their child’s dystonia preparatory to opting for neuromodulation 
intervention. The choice of goals clearly reflects a combination of the developmental progress 
of the child and motor severity across the whole spectrum of motor ability and dystonia 
severity. One way to describe the aim of neuromodulation is to expand the functional residual 
capacity of the child. This is related to but different from reducing dystonia, because the 
functional residual capacity is activity-related. An often understated aim of the baseline 
assessment is to help parents, carers and the MDT understand what matters most to the child 
and demonstrate to families the border-zone between successful and unsuccessful activity as 
well as those functions which are completely impossible. Goal-setting is explored from the 
border-zone of function, brought out during the assessment and is therefore clearly applicable 
to each individual child or young person.  
 
Meeting the neurosurgeon and concluding Phase I 
The formal surgical information and discussion meeting is a crucial multidisciplinary team 
event during which every aspect of the child’s case is reviewed, culminating in a review of 
the imaging, the neurophysiology, the MDT assessment and goals. The purpose here is to 
review what has already been discussed and allow the neurosurgeon to understand the 
parent/carer/child perspective(s) in relation to risk and benefit. Surgical risks, including risk 
of intra-cerebral bleeding leading to possible stroke or fatality (<1% across the literature), 
device infection, disappointment at lack of efficacy, and a variety of technical complications 
are reviewed based on published reports as well as our ELCH-KCH data. However we have 
been able to describe a much lower overall and specific complication rate in our large cohort 
of children than previously published in smaller cases series, including previously 
unpublished data for DBS in under 7-year-olds (56). Service-specific risk data is particularly 
difficult to achieve at the beginning of a service when limited team experience and the 
absence of a track-record necessitate reliance on published case-series. Broader information 
spanning all continents may soon be available through the auspices of a international 
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paediatric DBS registry (PediDBS) (13), aimed at collecting world-wide experience of 
childhood DBS. 
Another important way of helping with decision-making is for families and children to meet 
others who have been through the service already. Matching by age, aetiology and severity of 
dystonia is important. Meeting someone after recent DBS and also years later are important 
contrasting experiences. It is important for these meetings to be independent of the treating 
MDT. This is often also supplemented by a social media family support group (https://en-
gb.facebook.com/DystoniaSociety/posts/229880783722051) and advice from the Dystonia 
Society UK website, including the guide to good clinical practice (27).  
A new and important source of information has been our work with parents undertaking this 
complex decision-making (57) and the work of John Gardner, exploring DBS 
neuromodulation in children from a social sciences perspective which depicts the 
implementation of the ‘Broad Clinical Gaze’ as a means of defining what is in the child’s best 
interests based on promoting activity and participation (58, 59). As we have discovered, 
despite categorising our children with dystonia into the aetiological categories of primary or 
secondary, the actual efficacy of DBS for each specific child remains uncertain, in part 
because wide variations in responsiveness within each aetiological grouping is possible. 
Bridging the gap between published cohort and specific patient outcomes requires clinical 
experience and patience and the need to explicitly discuss ‘disappointment’ as a possible 
complication of DBS surgery. Further detailed information on how DBS works has been 
recently reviewed (6, 18, 19, 60, 61). Overall, honesty and candour still remain the best tools 
in the toolbox when facing these issues with the family together with the neurosurgeon. 
 
Phase 2 includes the DBS surgery and peri-operative care.  
Our neurosurgical practice has been previously described in detail (62-65) and with a few 
exceptions involves bilateral in-frame stereotactic targeting of the postero-infero-ventrolateral 
globus pallidus internus under inhaled isofluorane general anaesthesia preceded by a once-a-
day Octenasen total body head-toe shampoo for 5 days before DBS and 5 days of 
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perioperative cefuroxime iv antibiotics TDS for prophylactic infection reduction beginning 
with induction of anaesthesia at the start of DBS surgery. A single pass microelectrode 
recording is used to assess the ideal depth of the stimulating intracerebral electrode (62). 
Planned recovery from DBS surgery includes a nurse-controlled morphine infusion for up to 
24 hours post-operatively together with Ondansetron anti-emetic 8-hourly i.v. until nausea 
subsides. All regular anti-dystonia medication is usually restored on waking up from 
anaesthesia.  
Phase 3 involves post-operative multidisciplinary reviews at regular intervals of 1,2,3,6,9,12 
months and 6 monthly thereafter, both to monitor outcome and progress and for the MDT to 
work collaboratively with the family in order to ensure good neurostimulator recharging 
routines and maximise the effects of DBS on the young person’s functioning and participation 
in daily life. Usually, a BFMDRS test is performed at each visit along with a Timed Up and 
Go test (TUG) and six-minute walk, when appropriate. The majority of functional outcome 
measures take place are at 1, 2 and 5 years post DBS, though annual full MDT assessments 
would be the ideal to capture waxing and waning efficacy of DBS across the group, 
particularly in the light of recent information describing apparently on-going improvements in 
dystonia for each year of neuromodulation (66) rather than outcome saturation after the first 
year of DBS. Reviews are repeated sooner if clinically indicated.  
 
2. What we have learned from dystonia studies. An outline of functional clinical 
outcomes proposed (and open for discussion)  
A recent scoping review on the pharmacological and neurosurgical interventions available for 
dystonia and other HMD revealed 72 management strategies (include anticholinergic 
medication) all failed to address what mattered most to children and young people. For the 
majority of the interventional studies, the primary outcome measure was an impairment 
measure (5), most often, the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) (67) 
though Liow et al 2016, using the ICF-framework of functions and Dystonia Severity 
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Assessment Plan (DSAP) have shown that dystonia may respond well to Gabapentin (68) 
particularly if associated with pain, difficulty tolerating seating and poor sleep.  
More recently Koy et al 2016 (6) reviewed ‘advances in the management of movement 
disorders in children’ and it has been concluded that therapeutic options for children with 
dystonia remain an unmet need.  
A systematic review (69) on interventions for cerebral palsy (CP) only provided evidence of 
interventions for spastic CP without specific reference to dyskinetic CP. To date, no studies 
exist of non-medical/non-surgical interventions based on activity and participation in children 
with dyskinetic CP or any other HMD or even of specific sub-analysis of dyskinetic CP 
results within studies that might have included a few cases within larger spastic CP cohorts. 
Therefore generalisations of results in this population should be taken with caution.  
In this section we outline some key messages from the different studies currently available. 
This section is divided into different ICF domains: 
i) At the level of impairment. We particularly focus on assessment of dystonia 
severity, gross motor and upper limb function, assessment of cognition and 
executive function impairments and other non-motor components and finally 
evaluation of pain and sleep.  
ii) At the level of activity and participation we briefly describe the classification 
of functional abilities applied to dystonia and the evaluation of mobility, abilities 
in daily life activities and adaptive skills. We also include in this section some 
detail outline of goal-setting and objective evaluation of the goals.  
iii) Assessment of quality of life. Even though quality of life (QoL) is not an area 
that is measured by the ICF, this is an important area to measure in childhood 
disability.  
We acknowledge that there are also personal and contextual factors to consider and these are 
not discussed here as the knowledge of the influence of these factors is even less well-
understood. However we have also collected measurements of carer burden.  
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Given the lack of reports using functional outcome measures across different 
multidisciplinary teams, this guideline serves as a preliminary discussion point.   
 
Table 1 summarizes the strengths and challenges of impairment scales such as the BFMDRS 
and of functional outcome measures.  
Insert table 1 here 
Table 1: Challenges and Strengths of functional outcome measures vs the Burke-Fahn –Marsden 
Dystonia Rating Scale. 
 
BFMDRS – STRENGTHS 
Wide-spread use as a DBS outcome measure 
Systematic and structured evaluation 
Proven validity and reliability in adult primary dystonia 
No expensive resources required – relative ease of use 
Can be scored by a range of professionals 
Allows analysis of outcomes related to specific items 
Numerical result allows comparison over time within and 
between subjects  
Can be used in both paediatric and adult cases allowing 
continued use after transition. 
FUNCTIONAL OUTCOMES - STRENGTHS 
Intended for use in a paediatric (+/- adult) population. 
Measure skills relevant to daily life 
More likely to measure items that are meaningful to 
children and carers 
Useful tools to inform realistic goal setting  
Adds to understanding of impact of DBS on function and 
daily life 
Proven reliability  
Numerical result allows comparison over time within and 
between subjects  
BFMDRS – CHALLENGES 
No validation or reliability studies in paediatric population 
May require further validation for secondary dystonias 
Floor effects for more involved children 
Scoring criteria not adequately described 
Disability scale too crude 
Scores dystonia, not function or other impairments 
Non interpretive use of the movement scale may result in 
high scores despite little dystonia 
Functional outcome changes do not always correlate to 
similar trend in BFM score  
Potential Moving and Handling risks 
Requires cooperation and degree of cognition 
FUNCTIONAL OUTCOMES-CHALLENGES 
Significant clinical time required to implement and score 
Specialist skills/training required for some measures  
Resource intensive 
Discipline specific 
Implementation challenges: 
    - application difficult in highly disabled individuals 
    - variable ability - unable to apply all measures to all    
       cases 
    - impacts on between subject cohort comparison 
Not all are validated for use in dystonic movement disorders 
Paediatric v adult measures – change in measures used at 
transition 
Require cooperation and degree of cognition 
BFMDRS: Burke-Fahn-Marsden Dystonia Rating Scale, DBS: Deep Brain Stimulation 
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2.1 At the level of body function and structures. Level of impairment: 
2.1.1. Assessment of motor impairment:  
Dystonia Severity 
The BFMDRS rates dystonia severity and was originally developed in adults with primary 
dystonia though it has been applied almost systematically to children with secondary dystonia 
including dyskinetic CP and heredodegenerative conditions such as PANK-2 disorders. There 
have been several reports exploring the sensitivity of this measure by comparing the results 
with other measures of activity and participation (70-72) and goal attainment using the 
Canadian occupational performance measure (COPM) (70) and goal attainment scale (GAS) 
(72). Results in secondary dystonia show improvement in goal acquisition despite little 
change in dystonia severity as measured by the BFMDRS, partly because the scale magnifies 
the benefit of small changes to dystonia at the mild end of the dystonia spectrum compared to 
the severe end. For instance a 10 point change to someone with a baseline BFMDRS of 20 
results in a 50% improvement in dystonia. On the other hand, a 10-point change in BFMDRS 
to someone with a baseline of 100 gives only a 10% change. This has lead to the question: ‘to 
whom does a 10-point change in BFMDRS matter most?’ Another way of looking at this is to 
consider the idea of ‘Functional Residual Capacity” defined as [maximum BFMDRS-baseline 
BFMDRS]. Using this, a mildly affected subject with a baseline BFMDRS of 20-points 
retains a large amount of “Functional Residual Capacity” which does not change much after a 
10-point change. However, the subject with a baseline BFMDRS of 100 experiences a 
functional capacity gain of 50% after a 10-point drop in BFMDRS. Such considerations are 
leading to the use of absolute rather than relative changes in BFMDRS scores respectively.  
Further, preliminary analysis of the results using a blind-rated standardised outcome measure, 
the assessment of motor and process skills (AMPS) (45), are promising in showing 
significant, clinically important changes with an objective, blind-rated measure of functional 
ability despite relatively little BFMDRS change (22). Other impairment rating scales 
including those that differentiate between dystonia and choreoathetosis, the dyskinetic 
impairment scale (DIS) (73) have been proposed. Until now, no interventional studies using 
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DIS as a primary outcome measure exist to explore the feasibility of applying and scoring this 
for clinical purposes. However, the DIS does show that the dystonia component of the DIS 
contributes far more to disability that the chorea component of the DIS (74). This may explain 
why BFMDRS scores may remain elevated because of persistent choreoathetosis at rest and 
during activity maintains an elevated score even though the dystonic element may have 
diminished substantially.  
Published clinical findings are mainly limited to the neurological impairment. Given the 
heterogeneity of our sample, the validation of this scale in primary adult dystonia (36) or in a 
multicentre trial also with adult primary dystonia (mean age 51 (SD 14.8)) (75) might be 
challenged when applied to a group of secondary dystonias such as dyskinetic CP. Reviewing  
dystonia in children in 2013, Mink highlights the lack of  a perfect dystonia rating skill that 
has shown sound psychometric properties across all types of dystonia in childhood (76). This 
problem has now been partly overcome using a ‘Rosetta Stone’ method which ‘translates’ the 
BFMDRS impairment scale into three functional scales commonly used in CP classification 
for a group of primary, secondary (including CP) and progressive dystonias of childhood (67). 
The three functional scales have been used and validated in the world of cerebral palsy 
research (77) and comprise of i) the gross motor function classification system (GMFCS) 
(78), ii) the manual ability classification system (MACS) (79) and iii) the Communication 
Function Classification System (CFCS) (80).  
Gross motor severity: using the GMFM 
Some assessments of gross motor function have been classified under the ICF across more 
than one domain such as the gross motor function measure (GMFM) (37) which crosses body 
function and activity domains. To our knowledge, no systematic way of assessing the 
outcomes of interventions in dystonia exist using standardised assessments of gross motor 
function. Preliminary results using GMFM before and after DBS (81) have now been 
extended to a larger cohort of children and young people and this work will soon be available 
in the academic literature.  
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Upper limb severity: the QUEST and MA-2 
Similarly to the GMFM, measures of upper limb function often move across two domains of 
the ICF such as impairment and activity. This is the case for the Quality of Upper Extremity 
Skills Test (QUEST) (82) and the Melbourne Assessment 2 (MA-2) (83). Both assessments 
have been used in the measurement of the medical and surgical interventions (71, 84). The 
MA-2 assessment, for example, was improved from the original Melbourne upper limb 
assessment (85) with only 1 dyskinetic CP in the sample of children used to test psychometric 
properties of this UL tool. We are currently leading a validation process of the assessment 
using the MA-2 and establishing inter-rater and intra-rater reliability for dystonia in 
childhood. Whilst some established teams might have initiated measuring upper limb function 
using the original Melbourne, the authors have produced guidelines so that the scores can be 
extrapolated and used in the updated version of MA-2. This has advantages and might provide 
a better understanding of the difficulties that children and young people experience given that 
the MA-2 measures 4 distinct areas including: 1.Range, 2.Accuracy, 3.Dexterity and 
4.Fluency of movement (ROM) respectively. The combination of results from MA-2 and 
comparison with other outcome measures in dystonia could prove an interesting advance in 
the understanding of changes through interventions such as DBS. For example, one could 
hypothesise that changes in ROM for children without contractures and deformities might 
reflect a change in sustained postures (dystonia) whilst changes in dexterity and fluency might 
refer to a more phasic element of the disorder (rapid dystonia, choreoathetosis or tremor).  
There are other established upper limb assessments used such as the Assisting Hand 
Assessment (AHA) (86) or questionnaire-based Children Hand Use Questionnaire (CHEQ) 
(87) but these are tools to be used with children with unilateral involvement. Given that the 
highest proportion of dyskinetic CP include children with 4-limb involvement, tools such as 
AHA or CHEQ are not likely to be assessments widely adopted in the teams evaluating 
interventions such as DBS or ITB. Application of these tools to children and young people 
with asymmetric bilateral upper limb involvement should not be encouraged.  
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Upper limb assessment using kinematics 
Advancement in this area has been made in the last few years measuring upper limb 
movements using kinematics by a few groups (88-92). However, the use of kinematics in 
combination with other functional assessments to evaluate intervention outcomes is yet to be 
performed and kinematic impairment variables need to be analysed using principal 
component analysis to provide a ‘numerical snapshot’ for comparative and analytic purposes 
and then translated into a meaningful functional score. 
 
Quality of movement and selective movement control  
Quality of movement can be measured using the Quality Function Measure (QFM) (93). The 
QFM has been applied to a small sample of children and young people with dystonia and 
other HMD (94) in our centre, exploring the psychometric properties of the tool when applied 
to this heterogeneous group of children. The measure might be sensitive enough to capture 
changes following DBS for example. Changes in QFM could be correlated to other measures 
of gross motor function such as the GMFM as well as more functional measures across the 
domain of activities and participation such as the AMPS or Mobility assessments.  
The objective assessment of selective movement control (SMC) offers the clinician 
information about why a child might have functional difficulties, since dystonia alone might 
not be the only contributor to functional difficulties. Although assessment of SMC for the 
lower limb is routinely performed using standardised assessments, uptake of the SMC 
assessment for the upper limbs is scarce.  
 
2.1.2. Assessment of non-motor components in dystonia:  
In both the cerebral palsy and the dystonia literature, the focus on motor impairments 
dominate over non-motor components such as cognition and executive function. However, 
there are some interesting reports and studies focusing on non-motor factors, particularly in 
the adult population with dystonia (24-26, 95).  
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Assessment of cognition 
Reports have focussed on cognitive function in children with spastic CP (96) however Pueyo 
and colleagues compare children with spastic and dyskinetic CP (97) albeit only a small 
sample of dyskinetic CP and the classification is unclear (i.e. Dyskinetic diplegia). More 
specifically, there are now two relatively large sample reports for cognition stability before 
and after DBS in primary childhood onset dystonia (98) and secondary paediatric dystonia 
(99) and in a small group of Pantothenate Kinase Associated Neurodegenration (PKAN) 
dystonia (100). Owen and colleagues (2016) report an improvement on perceptual reasoning 
following DBS in secondary dystonia (99) and Mahoney (2011) reported improvements in 
tasks with a visual content such as picture concepts; vocabulary/picture vocabulary; visual 
immediate and delayed memory; faces immediate and delayed memory (100). Although these 
reports are promising, more work in this area is encouraged including the elimination of 
possible confounding variables and the role they might play in the improvement. 
Improvements noted in cognition could be due to several factors such as i) a reduction of 
medication after DBS, in cases of dystonia and other HMD, ii) improved motor ability to 
access tools and materials such as reduction of a dystonic neck pull that allows the child to 
keep the head in the mid-line for eye-gaze access (an improvement that the BFMDRS is 
unlikely to be sensitive enough to detect) and iii) the DBS has an independent effect on 
cognition by directly influencing the cognitive-associative basal ganglia-cortical loop.  
There are certainly challenges to measure cognition in this heterogeneous population, which 
comprise all levels of GFMCS, MACS and CFCS. Some children and young people are 
verbal whilst others can only communicate via eye-pointing for example. Manual Function 
will have an impact on what tests can be performed by the child and it is important that 
children and young people are not penalised for their movement disorder when they are 
attempting to access materials and tools for cognitive assessments. Unfortunately, there is 
probably no single measure that can be applied to the entire cohort with dystonia though an 
attempt should we made to assess our most severely affected children. In our group the joint 
work between psychology and occupational therapy has allowed some assessments to be 
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completed with children and young people that are both non-verbal and GFMCS level-V and 
who only have reliable eye pointing if they are handled outwith their wheelchair (e.g. on the  
lap) by their parents or an experienced therapist. We have attempted to maintain the therapist 
bias-free when interpreting eye movements whilst handling children by positioning the 
materials away from the therapist so that she/he cannot see what the answers are. We are in 
the process of describing in detail the practicalities of applying this approach to enable 
children to access psychological testing.  
 
Assessment of executive function 
The assessment of executive functions in childhood dystonia and their contribution to the 
understanding of baseline characteristics/profile has not been widely reported. In fact, this is 
an aspect that has not been widely studied even for children with spastic CP although some 
more reports are emerging (96, 101-104). The Behavior Rating Inventory of Executive 
Function (BRIEF) (105) is a parent-reported questionnaire but correlations with objective 
executive function scores/tests of assessments of adaptive skills are not yet available. Given 
the non-motor factors reported in the adult dystonia literature, it seems reasonable to measure 
this in childhood-related dystonia disorders. Again, as with cognitive assessments, the 
heterogeneity of the children and young people attending our service poses difficulties in 
terms of choosing only one assessment, so a core set of assessments should be considered 
depending on the motor-capacity of the child. We propose that these core sets of assessments 
are grouped not only on verbal or non-verbal capacity but also in relation to MACS and 
CFCS levels as they might serve as indicators of access-limitation to materials (many 
requiring manual function to use pen and paper).  
 
Motor-planning defines how a motor goal will be achieved (106). Steenbergen and colleagues 
have investigated motor-planning deficits in congenital hemiplegia as a possible underlying 
reason for difficulties in activities of daily living (ADL) (107, 108). Others have also 
investigated motor-planning ability in children with unilateral involvement (107, 109, 110) 
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and concluded that there was no relationship with functional ability though the latter was only 
measured by a questionnaire. These studies have been performed in spastic unilateral cerebral 
palsy. Although clinically many of the same issues might be present when assessing ADLs 
performed in dystonia, the pathophysiology of unilateral spastic CP and dystonic CP (or any 
other dystonia) is very different. In fact, the same group of authors recommend future 
rehabilitation efforts to be guided by treatment efficacy with specific pathophysiology (111). 
In our experience, there seems to be a significant element of motor planning which influences 
a child’s ability to perform ADLs but clearly the pathophysiology will be different to current 
available studies and we urge caution using recommendations taken from studies of spastic 
CP. A very recent report by Kukee and colleagues (2016) studied 11 children with 
hemidystonia (and some spasticity) using kinematics and concluded that the reduced 
coordination during movement could reflect deficits in motor planning (88). The possibility of 
visuospatial orientation (mental rotation) abnormalities in dystonic children also require 
evaluation when interpreting processing skills in dystonia.  
 
Assessment of Anxiety 
Reported in the adult primary dystonia literature (95), anxiety is a common feature observed 
in children and young people with dystonia attending our clinics. With some limited evidence 
on behavioral interventions in primary dystonia (23) there are currently no studies available in 
childhood dystonia.  
 
Assessment of Pain 
Pain is one of the most frequently reported areas of concerns by young people with dystonia 
and their families (5, 34) and improvements in dystonia pain have been recently reported with 
gabapentin (68). Pain is also a frequently reported concern for children with CP (112-114). 
Reduction of pain is possible with DBS even though significant changes might not be 
captured in terms of dystonia reduction (72). There are several pain assessments in use but 
again, the use of only one assessment for all children and young people might prove difficult 
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as some need the child to directly respond either verbally or using eye pointing (VAS) (115) 
and others might need to be used as a proxy measure by parents if the child is non-verbal or 
either too young or cognitively not able to provide a reliable answer such as the pediatric pain 
profile (PPP) (44). As pain reduction has been one of the most frequent goals identified by 
young people and their families in our cohort (5, 34), we have been able to use the COPM to 
measure changes in pain affecting daily life. The COPM can be used with all children and 
young people and their families and may be used to rate pain if this is a goal for intervention 
and it affects any day-to-day activities. More information is detailed in the goal-setting 
section below.  
Assessment of Sleep 
Sleep forms an essential component of health and well-being and is characteristically 
fragmented throughout life in children with dystonia. The Dystonia Severity Assessment Plan 
(DSAP: ‘dystonia soon as possible’) (116, 117) is based on two critical observations of 
wellbeing in dystonia of childhood: the ability to sit comfortably and sleep well at night 
(DSAP grade 1). Poor sitting tolerance but preserved sleep quality and quantity lowers the 
DSAP to grade 2. An inability to sit comfortably or sleep at night constitutes the need for 
urgent clinical review: DSAP grade 3 and may herald the rapid deterioration to metabolic 
decompensation (DSAP grade 4) and status dystonicus (DSAP grade 5) in short order. We 
have begun to use the DSAP to monitor the progress of children with severe, often brittle 
dystonia and measure improvements after gabapentin (68) along with the ICF domain on 
sleep: ‘Amount of sleep’ (B1340):  ‘Maintenance of sleep’  (B1342) graded 0-4 where 0=no 
impairment/difficulty; 1= Mild impairment/difficulty (present<25% of the time, intensity is 
tolerable, rare); 2= Moderate impairment/difficulty (present <50% of the time, intensity is 
interfering in day-to-day life, occasional); 3= Severe impairment/difficulty (present >50% of 
the time, intensity partially disruptive, often); 4= Complete impairment/difficulty (present 
>95% of the time, intensity totally disruptive, constant); 8= Not specified (insufficient 
information); 9=Not applicable 
Such assessments of sleep are important because of the beneficial impact of sleep in 
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‘switching off dystonia and chorea’ (118-120). 
 
2.1.3. At the levels of activity and Participation: 
Classification of function 
Well-established classifications of functional ability for gross motor (GMFCS) and manual 
function (MACS) are being used in studies of cerebral palsy. The use of these classifications 
in childhood dystonia studies (even when including dyskinetic CP) is less usual. We recently 
looked at the use of these two classification systems and included a more recent one 
classifying communication (CFCS) with childhood dystonia (both dyskinetic CP and other 
forms of childhood dystonia and other HMD) using a ‘Rosetta Stone’ approach, i.e.  
correlating the BFMDRS with the three motor function scales (67). The correlations between 
GMFCS and BFMDRS showed a clear linear relationship indicating almost equal blocks of 
20-25 BFMDRS points between each of the GFMCS levels. It could be argued that even for 
studies that are not describing the GMFCS levels, one could take the BFMDRS Movement 
Score and have an approximate idea of how functionally impaired the children in those 
studies might have been. Although correlations were high, the relationship between MACS 
and CFCS with the BFMDRS did not show such a clear linear relationship in the milder 
categories I, II and III, possibly indicating that a child’s ability to access communication and 
to perform ADLs is not purely down to motor but also that non-motor factors such as 
cognition or planning might have an important role. We recommend a minimal dataset for 
future studies to classify children and young people using these free, easy and quickly applied 
functional classifications so that comparison between populations and cohorts from different 
studies is possible.    
 
Evaluation of abilities in daily life activities, adaptive skills 
Since the literature is predominantly concerned with the domains of body structure and 
function, there is limited understanding of either functional characteristics of children and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
30
young people with dystonia and other HMD or of interventions to improve areas of daily life 
activities or ‘adaptive skills’ (5).  
‘Adaptive skill’s or ‘adaptive behavior’ include age-appropriate skills necessary to live 
independently. Often measured with questionnaires such as the Pediatric Evaluation 
Disability Inventory Computer Adaptive Test (PEDI-CAT) (121), the Vineland Adaptive 
Behavior Scales (Vineland-II) (122) or the Adaptive Behavior Assessment System (ABAS-II) 
(123). In childhood onset dystonia and other HMD, the use of these assessments has not yet 
been formally used. In one study using the PEDI, Öhrvall and colleagues explored the 
relationship between self-care and mobility skills and the MACS levels. They suggest a clear 
tendency for functional skills to increase with age and discuss the age at which different 
MACS levels are likely to achieve top scores on the PEDI. At age 9 with a MACS I and at 
age 12 with a MACS II compared to typical developing children aged 6 years 6 months (124). 
These recommendations whilst useful as a potential predictor might not hold when applied to 
children with dystonia other HMD including dyskinetic CP. For example, in the above study, 
the children with dyskinetic CP were all classified MACS III-V. Caution therefore should be 
taken when applying research results that are mainly based on spastic CP to children and 
young people with dyskinetic CP. The use of this relatively inexpensive assessment across 
different centres, together with MACS and GMFCS classifications could provide us with 
large enough numbers to explore the relationship between these classifications systems and 
the PEDI-CAT.  
An objective assessment that focuses on activities of daily living is the Assessment of Motor 
and Process Skills (AMPS) (45). Better understanding of motor and non-motor baseline 
characteristics of children and young people with HMD would aid us in developing more 
targeted interventions in our cohort of children. Preliminary evidence using AMPS pre- and 
post-DBS is available (22). 
One issue remains in finding an appropriate outcome measure that could be applied to such a 
heterogeneous population with different levels of motor severity, pathophysiology and 
functional ability. However, given that the focus and priorities of children and young people 
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and their families revolve around every day activities, there is a need for measuring outcomes 
around this domain.  
Our assessment process includes a repertoire of imaging and medical testing but goes beyond 
the impairment level (as outlined in the WHO ICF framework) and also assesses other areas 
that could influence the child/young person’s ability to participate fully in all activities of 
daily living and in the community.  
The extent to which outcome measures generate future goals will be explored. 
 
2.1.4. Goal-setting in dystonia 
Finding out the real priorities and concerns for young people with movement disorders such 
as dystonia, particularly those that undergo DBS, will enhance our knowledge of what is 
really important for these young people and how we can help address those areas of concern 
and need. Tools, such as the Canadian Occupational Performance Measure (COPM) (51) and 
the Goal Attainment Scale (GAS) (52), directly identify and measure client/carer concerns 
and the extent to which the intervention has led to meaningful change in these areas.  These 
tools provide a meaningful way of measuring how well we are able to pre-operatively predict 
an individual’s response to DBS, which is useful in informing future client selection, as well 
as identifying goal areas more likely to be responsive to the intervention.  Such a model is 
applicable to a range of interventions and is widespread in paediatric practice, which we 
consider an essential benchmark for the delivery of a complex motor disorder service for 
children and young people offering invasive interventions such as DBS. 
The implementation of formal goal-setting for DBS therapy, using the COPM, over a period 
of some years has made it possible for our service’s therapists to counsel parents about DBS 
results based on therapist experience with a cohort of more than 130 children implanted since 
2007. For instance, our accumulated experience indicates frequently positive outcomes with 
regards to pain and comfort but typically little response in terms of speech intelligibility in 
children with secondary dystonia. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
32
There have been a number of challenges to embedding current goal-setting practice. 
Occupational therapists and physiotherapists need to comprehensively evaluate the child in 
order to determine the primary impairments contributing to the functional difficulties and the 
extent to which the intervention (DBS) may address these.  For example, impairments 
commonly seen in association with dystonia in our patient group include hypotonia, reduced 
selective motor control, contracture and deformity, and planning and organisational 
difficulties, yet DBS would not directly address all these aspects, except in the sense that 
dystonia comprises both hypertonia and hypotonia i.e. both extremes of tone and posture 
range and DBS stabilises the lurching of the motor system from one extreme to another. The 
posssibility of fluctuating mood, behaviour or even cognitive functions in dystonia in 
childhood requires further exploration. The challenge is to identify which areas may 
reasonably be expected to improve should DBS successfully ameliorate involuntary postures 
and movements and how those will influence function and participation.  We have found it 
useful to defer formal goal-setting until the end of the assessment process, allowing a more 
comprehensive picture to be built-up between family and allied health professionals regarding 
the factors contributing to the child’s functional difficulties and a good rapport has been 
established to allow for honest, open discussions about expectations on both sides. 
 
Parents and carers will often identify an impairment area and need prompting to identify the 
related functional difficulty. For example, a parent may initially state that their goal would be 
for their child to move less, while with prompting may identify that reducing involuntary 
movements would allow their child to be safely placed on an adapted toilet seat for toileting 
or to safely spend leisure time on the sofa with siblings. In this way, the aim is to demonstrate 
the extent to which reduction in dystonia and dyskinesia through neuromodulation positively 
improves day-to-day activities the child and family identify as important. Describing a 
specific functional concern is also easier to quantify than the subjective reporting of 
improvement or deterioration in involuntary movements.  
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In practice, it can be time consuming to formally document goals and agree means by which 
progress in goal-areas will be measured. This is particularly an issue at the initial goal-setting 
episode, as the pre-operative semi-structured COPM interview may typically take an hour or 
more, albeit with substantial variations.  We think this time is fully justified and manageable 
given the importance in capturing ‘what matters most’ and what would constitute an 
improvement, before proceeding to DBS implantation.   
 
Follow-up evaluations are less time consuming. We have found the clear qualitative 
descriptions of areas of concern can serve as very useful prompts during feedback and as 
useful reminders of a child’s state some time previously when parental recall may not be 
reliable. For example, when asked how an area such as sleep has changed, a parent may say 
the situation is unchanged, yet the child may be described as now waking only once a night 
for a drink in contrast to parents being up 5-6 times a night for protracted periods due to 
painful dystonic spasms. In this way, the goal-setting process helps both families and 
professionals to remain focused on the areas that were identified as concerns prior to surgery 
providing clarity on the extent to which meaningful progress has been made. 
 
We have noted cultural, emotional and personality influences in the COPM scoring process. 
For example, a parent may describe an area presenting significant care difficulty and rate poor 
performance for this concern, but not overtly express dissatisfaction with the problems they 
experience as they consider it their “duty” to meet their child’s needs.  
 
Goal-setting in progressive neurodegenerative disorders, such as pantothenate kinase 
neurodegeneration (PKAN), has proven particularly challenging and formal goal-setting tools 
such as the COPM may not be appropriate in all cases.  In these conditions, positive progress 
may be only briefly achieved for 1-2 years, but stability or a change in the rate (profile) of 
deterioration may represent successful intervention.  Further, with time, the inevitable and 
inexorable deterioration can make it difficult to ascertain the extent to which DBS is 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
34
significantly ameliorating the child’s movement disorder and improving the child’s quality of 
life.  We have had experience in some PKAN cases, where the young person has rapidly gone 
into status dystonicus following inadvertent de-activation of the DBS, which resolved quickly 
with reactivation.  Such experiences have highlighted to both families and clinicians the 
extent to which DBS may be positively contributing to a child’s management, despite the 
persistent and severe dystonia, which may be present when the DBS is active.  Clearly, it 
would not be ethical, nor desirable, to inactivate DBS to evaluate efficacy, particularly given 
concerns of precipitating status dystonicus as a rebound phenomenon following DBS 
cessation (116). 
 
Objective and blind rating evaluation of goals: 
PQRS 
As Mink (2013) points out, movement disorders in childhood are a heterogeneous group and 
there are challenges not only with definition of their diagnosis but also with assessment and 
treatment (management) across different aetiological background, motor severity and age 
(76).  
As with other populations, the use of goal-setting has been proven possible and sensitive to 
capture change following surgical interventions (70, 125) but one argument would be that 
goal-acquisition reporting with tools such as the COPM is a self-reported outcome and 
therefore lacks the objectivity that many claim necessary for the systematic evaluation of 
interventional outcomes. With the challenges of applying the same assessment across this 
heterogeneous population, the use of client-centred and client-chosen goals is promising. The 
objective evaluation of those goals is possible and has been tested in studies using a specific 
intervention named cognitive orientation to daily occupational performance (CO-OP) (126-
129). Using the Performance Quality Rating Scale (PQRS) (46) it is indeed possible to 
objectively measure client-selected functional goals. A study validating the use of PQRS for 
dystonia and other HMD is currently in progress (130). This is a promising tool that would 
allow a systematic study of objective measurement of goal acquisition and comparison with 
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self-rated goals from the children and families perspective. It could be used across any age, 
GMFCS, MACS or CFCS level and across any aetiological background.  
 
2.1.5. Assessment of quality of life  
Quality of life (QoL) is not yet included in the ICF and is often considered separately. Often 
used as an outcome for research studies in cerebral palsy (131) and in adult movement 
disorders. In childhood dystonia, Eggink et al. 2014 recently reported the health related 
quality of life (HRQOL) in rare inborn errors of metabolism with movement disorders (132). 
QoL is self-reported and it can be used towards studying health economics calculations. 
HRQOL questionnaires are self-reported and can be easy and quick to administer. Cost 
effectiveness of a study can therefore be calculated using cost per quality-adjusted life years 
(QALYs) where possible. For example, the EQ-5D-5L (133) is a generic, preference based, 
HRQOL that has 3 versions, making it possible to apply independently of the age; EQ-5D-Y 
(for children under the age of 12), EQ-5D-3L (for young people aged 12-18) and EQ-5D-5L 
(for young adults and adults). 
2.2. Can we learn from studies of dystonia in adults or from studies of CP? 
When evaluating treatment interventions with childhood onset dystonia and other HMD, the 
evidence other than pharmacological or neurosurgical is scarce and disappointing. From 
Novak’s review in 2013, the non-pharmacological/surgical interventions that were classified 
as green (meaning that there was enough and strong evidence to support such interventions in 
CP), mostly applied to children and young people with spastic CP, the majority unilateral 
(spastic) CP (69). When reviewing the studies mentioned in Novak’s systematic review on 
bimanual training, constrained induced movement therapy, context-focused therapy and goal-
directed training, all studies either mentioned that the inclusion criteria was spastic CP or did 
not mention whether they included dyskinetic CP, nor did they analyse this subgroup of 
patients separately. Only one study for goal-directed training (home programmes) by Novak 
et al. 2009 included 5 children with dyskinetic CP from a total of n=36 (134). Whilst this is 
encouraging, the study had 3 arms for intervention (i) 8 week occupational therapy home 
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programme (OTHP), ii) 4 weeks OTHP and iii) No OTHP). Due to the small number of 
dyskinetic CP, randomisation only took place to the 4week OTHP and no OTHP and no 
children with dyskinetic CP in the 8week OTHP. We acknowledge that stratifying by 
phenotype would have been difficult with such small percentage of children and young people 
with dyskinetic CP.  
 
This is also the case for childhood stroke and as Ganesan (2013) points out, current rehab 
approaches are rarely evidence-based and based usually on children with spastic CP (135). 
Ganesan urges rehab approaches to focus on the pattern of impairment rather than diagnosis, 
for example dystonia rather than spasticity, which is more likely after arterial ischemic stroke 
in children. Yet again, most stroke rehabilitation approaches target spasticity. The literature 
on hemiparesis following perinatal stroke is altogether different, partly based on early 
recognition it has been possible to develop population-based interventional studies of CIMT 
and HABIT alone or combined with transcutaneous Direct Current Stimulation (tDCS) in the 
state of Alberta, Canada, and this clinical-epidemiological/population-developmental 
neurobiological multidisciplinary model, along with the background scientific literature has 
been extensively reviewed by Adam Kirton (136).   
 
A subsequent literature search was performed using the terms ‘dystonia’ OR ‘hyperkinetic 
movement disorders’ OR ‘athetosis’ OR ‘dyskinetic cerebral palsy’ AND ‘rehabilitation’ OR 
‘occupational therapy’ OR ‘physiotherapy’ OR ‘goal-oriented intervention’ OR ‘behavioural 
intervention’ AND ‘children’ OR ‘childhood’ in order to capture any results from 
interventions since the published systematic review of systematic reviews by Novak et al. 
2013 (69). The results did not show any other pattern in terms of the available reports, mainly 
including studies developed for inclusion of children with spastic CP.  
 
Despite the absence of clear evidence supporting their use, some authors report on the 
desirability of frequent of physiotherapy and occupational therapy sessions to be delivered 
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(137) though this is not based in actual evidence-supported studies.  A recent review paper on 
current and emerging strategies for children with dystonia outlines current intervention 
strategies, though these again are not based on evidence (92).   
 
Is there a role for biofeedback interventions in childhood dystonia? 
Biofeedback in childhood dystonia may be volunteered as useful for learning though this is 
not based on learning for every day activities and it relates purely to lab based learning 
studies (88, 92). Interestingly the authors make an assumption that sensoriomotor 
impairments in childhood dystonia hamper acquisition and consolidation of gross and fine 
motor skills crucial for cognitive and social development. However, it could be debated that 
these paradigms have not yet been tested since very few if any studies look at the relationship 
between sensoriomotor impairments and acquisition and consolidation of such impairments.  
Casellato and colleagues describe two studies in 2012 and 2013 (138, 139) exclusively with 
children with primary dystonia to improve motor control with EMG-based visual-haptic 
biofeedback (138) and with error enhancing robot therapy (139). Again, reporting only at the 
impairment level makes any generalisation to real life situations doubtfully meaningful and 
conclusions cannot be drawn on whether those changes are in fact clinically significant for the 
child/young person or in terms of their ability to learn new activities. In our experience, 
children with primary dystonia continue to have difficulties with day-to-day activities even 
when dystonia severity is reduced significantly (22) given their non-motor co-morbidities. 
Therefore motor-learning based approaches might have to include elements beyond 
sensoriomotor rehabilitation or robot generated deviating forces.  
 
Ongoing registered trials on childhood dystonia 
On a review of the International Standard Randomised Controlled Trials Number Registry 
(ISRCTN) we only found 1 study currently in progress. The study is led by the first author of 
this manuscript (Gimeno, H) and registered ISRCTN57997252 investigating the role of a 
cognitive-based approach in childhood onset and other HMD using two consecutive series of 
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N-of-1 trials (140). We are aware of one other pilot study using eye gaze technology with 
young children with dyskinetic CP but this is not registered and is currently underway 
(personal communication with Petra Karlsoon, June 2016).  
 
Recommendations for future research are outlined in the last section of this manuscript with 
proposals about potential designs to improve our understanding and knowledge of childhood 
dystonia and outcomes.  
 
3. Recommendations for multi-centre collaboration in regards to functional clinical 
outcomes and future research methods 
Primary and secondary dystonia might have more in common than comparisons or 
extrapolated recommendations from spastic CP studies to dystonia. This follows the saying: 
‘dystonia, is dystonia, is dystonia’ regardless of aetiology, so the important strategy is to build 
on existing models of dystonia. 
Given the progress with genetics (see Silveira-Moryama and Lin 2015 for further discussion) 
(9) children with a diagnosis of CP may later on be diagnosed with genetic diagnoses such as 
dopa-responsive dystonia (DRD), other monogenetic dystonias such as benign hereditary 
chorea or even an NBIA (9) but new genes, possibly more common than those currently 
reported are also emerging so we should therefore develop interventions that can work across 
different aetiological groups in dystonia and other HMD, looking at shared features amenable 
to intervention as well as specific differences such as timing of onset and the impact of the 
proportion of life lived with dystonia at a time-critical period of early motor development 
(65). 
We propose below some points to initiate discussion and suggestions for future collaboration.  
 
Suggestions for the future: 
1. Validation of outcome measures: 
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Having a non-homogeneous group of young people presents challenges throughout any 
management strategy implementation such as DBS neuromodulation. Given the limited 
psychometric testing in well-known outcome measures in CP, which have been mainly tested 
in spastic CP, we urge caution when applied to childhood dystonia and other HMD.  
Ideally, collaborative work between centres that have experience in applying outcome 
measures with dystonia should be a priority in terms of validating these measures. This 
requires incorporation of allied health professionals as core members of the multidisciplinary 
team.  
 
2. Allied Health Professionals embedded in multidisciplinary teams: 
It is our impression that there are limited clinical services with bespoke multidisciplinary 
team approaches to assessment and management of children with movement disorders and 
this might be a reason for a lack of reports addressing domains of the ICF beyond impairment. 
Hence, our limited knowledge about effective interventions in domains of activity and 
participation in the paediatric population, particularly secondary dystonias. It will therefore be 
difficult to anticipate possible outcomes and establish realistic goals with young people and 
families. We would encourage multidisciplinary teams to include not only physiotherapy but 
also occupational therapy, speech and language therapy and psychology colleagues. One 
proposal will be to join forces in describing goal-acquisition with current available studies in 
DBS and ITB measured with COPM and GAS. We acknowledge that intense training and 
work across disciplines in the initial period with professionals working often outside their 
specific therapy/medical roles will be needed. Ideally, a training package agreed by 
international consensus (including AHPs) might be a way forward.  
 
3. Applying dystonia severity scales: 
Most often international teams focus on impairment with use of dystonia rating scales, which 
is undoubtedly an important area to describe. Given the heterogeneity of our groups and the 
difficulties applying a well-established and internationally used outcome measure such as the 
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BFMDRS to a population with severe disability (above 100 out of 120 in BFMDRS) we 
propose, as a minimum, that studies report not only a dystonia severity scale but also 
functional ability classification systems, the GMFCS at a minimum but ideally together with 
the MACS and CFCS.  
 
4.Capturing the variability in dystonia: 
Variability of performance is characteristic in childhood dystonia and other HMD. Often 
described as variability within the same hour, day or week, the importance of multiple 
baselines before intervention may be warranted in this population. Randomised controlled 
trials, though considered the gold standard, might not be appropriate for these children and 
young people as a single data point before and after intervention will fail to capture real life 
performance (i.e. Variability). A potential goal for intervention could be in fact to reduce such 
a prominent variability, so that performance becomes more stable which in turn might give 
children and young people more confidence to try new things.  
 
5. Research design in childhood dystonia and other HMD: 
We have outlined the limited evidence and research in childhood dystonia. Mink 2013 
highlights how most dystonia ‘treatments’ are designed for and tested in primary dystonia and 
the ability to generalize these findings for dyskinetic CP or any other form of secondary 
dystonia is limited (76). We agree that there continues to be an increasing need for further 
experimental therapeutic research in this population.   
 
Recommendations to consider methodological approaches using proof of principle and pilot 
studies to allow for subsequent well-designed randomised, controlled trials, and long-term 
observational trials have been made (6, 76, 141). The use of single-case experimental design 
or N-of-1 trials using multiple replications across subjects could offer an answer to some of 
the problems with variability and methodological issues.  
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Conclusions:  
We present a comprehensive scheme for approaching movement disorders in children, 
including dystonia and choreoathetosis of necessity originating from many disparate 
aetiologies. Searching for common themes has helped us as a clinical group, to define core 
issues relating to refinement of the phenotype with neurophysiological (62, 142), radiological 
(63, 143, 144) and functional metabolic (145) assessments respectively. These approaches 
help us understand the physiological context of dystonia and contribute to patient-selection 
for DBS and also allow interpretation of outcomes, which further refines the selection 
iteration process. Goal-focussed practices confer an understanding of meaningful outcomes, 
which in turn result in contented children and families. However past goals must be replaced 
by future objectives. The dynamic needs of the child, young person, families and carers 
constitutes the need to incorporate ‘resilient’ assessments, and perhaps more importantly 
resilient perspectives among referring and treating clinicians, children, young people, device 
manufacturers and the health-care providers. Neuromodulation for dystonia in children is now 
at last becoming accepted as a rich, legitimate field of clinical practice which demands as 
never before a multidisciplinary clinical-research approach to drive our clinical models 
towards desirable ‘virtuous outcome spirals’ in which each iteration leads to improved 
function, activity and participation. This and many other contributions to this special edition 
on Advances in Neuromodulation in Children indicate that although there are no ‘quick fixes’ 
the prospect for lasting meaningful benefits in chronic, disabling dystonias of childhood are a 
tangible reality. The challenges of patient stratification for precision medicine-in this case 
functional neuromodulation neurosurgery- must be grasped wisely. 
 
The lack of studies in childhood dystonia across any intervention other than pharmacological 
or neurosurgical approaches, which themselves often fail to capture what matters most to 
children and their carers (5), calls for immediate action from the clinical-scientific community 
to generate new knowledge on interventions that might be possible with this group of patients. 
This might require a paradigm shift and the application of knowledge of motor control and 
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motor learning theories, together with learning and cognitive paradigms to improve outcomes 
for children and young people with dystonia and other HMD.  
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Highlights:  
A comprehensive scheme for approaching movement disorders in children, including 
dystonias and choreoathetosis of heterogeneous aetiology is presented. 
 
Searching for common themes helps to define core issues relating to refinement of the 
phenotype with neurophysiological, radiological and functional metabolic assessments 
respectively.  
 
These approaches help selection for DBS and also allow interpretation of outcomes, which 
further refines the selection iteration process.  
 
Goal-focussed practices confer an understanding of meaningful outcomes, which in turn 
result in contented children and families.  
 
The dynamic needs of the child, families and carers constitutes the need to incorporate 
‘resilient’ assessments, and perhaps more importantly resilient perspectives among referring 
and treating clinicians, children, young people, device manufacturers and the health-care 
providers.  
 
